Recruiting nowPhase 2
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Updated 2026-06-05 · NCT05356104See eligibility →
Treatment
GLP-1 receptor agonist clinical trials
Active studies that list GLP-1 receptor agonist as an intervention or treatment.
9active studies
5recruiting now
4countries represented
36largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-04-17 · NCT06903923See eligibility →
Recruiting nowPhase 4
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Updated 2026-04-13 · NCT05390892See eligibility →
Recruiting nowPhase 4
Impact GLP-1 Agonists Following Bariatric
Updated 2026-01-22 · NCT06132477See eligibility →
Recruiting nowNot applicable
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Updated 2025-12-30 · NCT07309094See eligibility →
Opening soonNot applicable
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
Updated 2026-07-07 · NCT07687667See eligibility →
Updated 2026-01-02 · NCT07314528See eligibility →
Opening soonNot applicable
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity
Updated 2025-01-14 · NCT06775093See eligibility →
Active, not recruitingNot applicable
Comparison of Body Composition Changes With Weight Loss Interventions
Updated 2026-07-14 · NCT07115069See eligibility →
Related treatments
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.